Building an AI and robotics platform for drug discovery. They are focused on the medicinal chemistry process bringing a hit to lead in small-molecule drug development
Location: United States
Total raised: $8.9M
Investors 1
| Date | Name | Website |
| 05.02.2026 | Foothill V... | foothill.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.07.2025 | - | $8.9M | - |
Mentions in press and media 5
| Date | Title | Description |
| 09.07.2025 | Synfini: $8.9 Million Discovery Funding Secured For Speed Small Molecule Drug Development | Synfini, an AI-driven chemistry automation, announced an $8.9 million expansion of its funding round, led by JSL Health Capital and supported by a strong group of early-stage investors. This brings Synfini’s total funding to $53 million, fe... |
| 07.07.2025 | Synfini gets $8.9M to accelerate drug discovery with AI Join theCUBE Alumni Trust Network Send us a News Tip EXTRACT THE SIGNAL FROM THE NOISE Cookies | Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health Capital, bringing its total amount raised to date to $53 million. The company has made a name for itself by combining ... |
| 07.07.2025 | Synfini Raises $8.9M in Expansion Funding | Synfini, Inc., a Menlo Park, CA-based company which specializes in AI-driven chemistry automation, raised $8.9M in expansion of its funding. The round was led by JSL Health, with participation from investors including SRI Ventures, WERU Inv... |
| 13.10.2023 | ウエルインベストメントがSRI発の創薬AIベンチャー企業へのリード投資を実行 | ウエルインベストメント株式会社（以下、ウエルインベストメント）は、この度SRI International（以下、SRI）よりスピンアウトされた創薬AIベンチャー企業のSynfini, Inc.（以下、Synfini）にプレシードラウンドにてリード投資を実行したことをお知らせいたします。Synfiniは、今回のスピンアウトで、SRIにて$40M以上の研究開発を経て確立されたSynfiniプラットフォームの一連の特許の権利を取得し、今後、グローバルな創薬産業に向けて次世代の創薬... |
| - | Synfini | “synfini – synfini” |